Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current treatments for CIDP.

Allan H Ropper1

  • 1Saint Elizabeth's Medical Center/Tufts University School of Medicine, Boston, MA, USA. Allan_Ropper_MD@cchcs.org

Neurology
|April 23, 2003
PubMed
Summary
This summary is machine-generated.

Current chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) treatments offer limited long-term benefits and pose challenges. Combination therapies may offer improved efficacy and durability for CIDP patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Small Steps, Big Ventricles: Idiopathic Normal-Pressure Hydrocephalus.

The New England journal of medicine·2025
Same author

Neuroleptic Malignant Syndrome.

The New England journal of medicine·2024
Same author

Transient Global Amnesia. Reply.

The New England journal of medicine·2023
Same author

Transient Global Amnesia.

The New England journal of medicine·2023
Same author

Migraine - Patient Perspectives.

The New England journal of medicine·2022
Same author

Migraine - Treatment and Preventive Therapies.

The New England journal of medicine·2022
Same journal

Factors Associated With Disability Improvement and Worsening Independent of Attacks in Patients With AQP4-IgG+ NMOSD and MOGAD: A Multicenter Cohort Study.

Neurology·2026
Same journal

Cost-Effectiveness of Intracranial Aneurysm Screening: A Systematic Review.

Neurology·2026
Same journal

Rare Eating Epilepsy: Co-Occurrence of Focal Cortical Dysplasia and Gray Matter Heterotopia.

Neurology·2026
Same journal

Spatiotemporal Associations Between Cortical Microinfarcts and Cortical Superficial Siderosis in Cerebral Amyloid Angiopathy.

Neurology·2026
Same journal

Blood-Brain Barrier Disruption Before Interhospital Transfer for Thrombectomy and Clinical Outcome.

Neurology·2026
Same journal

At Death's Door: Cytosolic Dopamine in Patients With Parkinson Disease.

Neurology·2026
See all related articles

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune disorder affecting peripheral nerves.
  • Current standard treatments include intravenous immunoglobulin (IVIg), corticosteroids, and plasma exchange (PE).

Purpose of the Study:

  • To review the efficacy and tolerability of existing CIDP therapies.
  • To identify limitations of current treatments for long-term management.
  • To explore the potential of combination therapy for CIDP.

Main Methods:

  • Literature review of studies on IVIg, corticosteroids, and PE for CIDP.
  • Analysis of treatment efficacy, durability, and safety profiles.
  • Evaluation of combination therapy as an alternative approach.

Related Experiment Videos

Main Results:

  • Current therapies are effective in about two-thirds of CIDP patients but lack durable responses.
  • IVIg, corticosteroids, and PE have significant limitations including cost, administration burden, safety concerns, and invasiveness.
  • Combination therapy presents a potential strategy to enhance treatment efficacy and duration.

Conclusions:

  • Existing CIDP treatments are partially effective but problematic for long-term use.
  • Further research is necessary to identify optimal agents for single and combination therapies in CIDP.
  • Combination therapy warrants investigation to improve outcomes for CIDP patients.